These include transcriptional and translational regulators of PKD1/PKD2, modifier genes (e.g., cyst formation, type IV collagen), and genetic variants linked to chronic kidney disease (CKD) risk factors such as obesity, dyslipidemia, hypertension, and diabetes [11,12]. This evidence concerns the gene PKD2 and metabolic syndrome.